Raymond James Reiterates Strong Buy Rating on Liquidia Technologies (LQDA)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
LifeSci Capital Reiterates Outperform Rating on Liquidia Technologies (LQDA)
October 8, 2024 6:09 AM EDTLifeSci Capital analyst Cory Jubinville reiterated an Outperform rating and $30.00 price target on Liquidia Technologies (NASDAQ: LQDA)
The analyst comments "As we highlighted in our recent initiation (link here), the commercial launch of Liquidias (Nasdaq: LQDA) Yutrepia has been held back due to patent suits brought forward by United Therapeutics (Nasdaq: UTHR) regarding two key patents: 793 and 327. The 793 patent had previously been deemed invalid by the Federal Circuit for... More
BTIG Reiterates Buy Rating on Liquidia Technologies (LQDA)
October 7, 2024 1:01 PM EDTBTIG analyst Julian Harrison reiterated a Buy rating and $25.00 price target on Liquidia Technologies (NASDAQ: LQDA).
The analyst comments "As we expected, the Supreme Court of the United States has denied UTHR's (Neutral) writ of certiorari request to challenge the prior invalidation of... More
